Abuse and dependence potential of sphingosine-1-phosphate (S1P) receptor modulators used in the treatment of multiple sclerosis: a review of literature and public data.
Psychopharmacology (Berl). 2022 Jan;239(1):1-13. doi: 10.1007/s00213-021-06011-6. Epub 2021 Nov 13.
Psychopharmacology (Berl). 2022.
PMID: 34773483
Free PMC article.
Review.